Climate impact of early-stage NSCLC treatment: A comparison between radiotherapy and surgery using Life Cycle Assessment.

Carbon footprint Climate impact LCA Life Cycle Assessment NSCLC Radiotherapy SBRT VATS surgery

Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
29 Oct 2024
Historique:
received: 06 06 2024
revised: 24 09 2024
accepted: 26 10 2024
medline: 1 11 2024
pubmed: 1 11 2024
entrez: 31 10 2024
Statut: aheadofprint

Résumé

Healthcare systems contribute significantly to CO We used life cycle assessment(LCA) to evaluate climate impact in emissions of kilograms of CO Using LCA we calculated the impact of all categorized contributions for two treatments for NSCLC. In total, VATS generates approximately 547 kg CO When treating T1-2N0M0 NSCLC, surgery has a larger climate impact than SBRT. For both modalities reductions are possible.

Identifiants

pubmed: 39481607
pii: S0167-8140(24)04263-4
doi: 10.1016/j.radonc.2024.110601
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110601

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jochem Kaas (J)

Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.

Marit Verbeek (M)

Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.

Wilson Wan Lung Li (W)

Department of Cardiothoracic Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.

Stefan van der Heide (S)

Department of Cardiothoracic Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.

Ad Verhagen (A)

Department of Cardiothoracic Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.

René Monshouwer (R)

Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.

Hugo Rutger Willem Touw (H)

Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.

Jan Bussink (J)

Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.

Erik van der Bijl (E)

Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: erik.vanderbijl@radboudumc.nl.

Tim Stobernack (T)

Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.

Classifications MeSH